<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="31355">Carboplatin</z:chebi>, [Pt(<z:chebi fb="0" ids="16134">NH3</z:chebi>)2(CBDCA-O,O')], 1, where CBDCA is <z:chebi fb="0" ids="35690">cyclobutane-1,1-dicarboxylate</z:chebi>, is used against ovarian, lung, and other types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We recently showed (Di Pasqua et al </plain></SENT>
<SENT sid="2" pm="."><plain>(2006) Chem </plain></SENT>
<SENT sid="3" pm="."><plain>Res </plain></SENT>
<SENT sid="4" pm="."><plain>Toxicol </plain></SENT>
<SENT sid="5" pm="."><plain>19, 139-149) that <z:chebi fb="2" ids="31355">carboplatin</z:chebi> reacts with <z:chebi fb="124" ids="41609">carbonate</z:chebi> under conditions that simulate therapy to produce carbonato <z:chebi fb="2" ids="31355">carboplatin</z:chebi>, cis-[Pt(<z:chebi fb="0" ids="16134">NH3</z:chebi>)2(O-CBDCA)<z:chebi fb="0" ids="29376">(CO3)</z:chebi>]2-, 2 </plain></SENT>
<SENT sid="6" pm="."><plain>We use <z:chebi fb="18" ids="36928">13C</z:chebi> and 1H NMR and UV-visible absorption spectroscopy to show that solutions containing <z:chebi fb="2" ids="31355">carboplatin</z:chebi> that have been aged in <z:chebi fb="124" ids="41609">carbonate</z:chebi> buffer under various conditions contain 1, 2, and other compounds </plain></SENT>
<SENT sid="7" pm="."><plain>We then show that aging <z:chebi fb="2" ids="31355">carboplatin</z:chebi> in <z:chebi fb="124" ids="41609">carbonate</z:chebi> produces compounds that are more toxic to human <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> (SK-N-SH), proximal renal tubule (HK-2) and Namalwa-luc Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells than <z:chebi fb="2" ids="31355">carboplatin</z:chebi> alone </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, increasing the aging time increases the cytotoxicity of the <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> solutions as measured by the increase in cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Although HK-2 cells experience a large loss in survival upon exposure to carbonato forms of the drug, they have the highest values of IC50 of the three cell lines studied, so that HK-2 cells remain the most resistant to the toxic effects of the carbonato forms in the culture medium </plain></SENT>
<SENT sid="10" pm="."><plain>This is consistent with the well-known low renal toxicity observed for <z:chebi fb="2" ids="31355">carboplatin</z:chebi> in therapy </plain></SENT>
<SENT sid="11" pm="."><plain>The uptake rates for <z:mpath ids='MPATH_458'>normal</z:mpath> Jurkat cells (NJ) and <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-resistant Jurkat cells (RJ), measured by inductively coupled plasma mass spectrometry (ICP-MS), are 16.6 +/- 4.2 and 12.3 +/- 4.8 amol of Pt h-1 cell-1, respectively, when exposed to <z:chebi fb="2" ids="31355">carboplatin</z:chebi> alone </plain></SENT>
<SENT sid="12" pm="."><plain>However, when these cells are exposed to <z:chebi fb="2" ids="31355">carboplatin</z:chebi> that has been aged in <z:chebi fb="124" ids="41609">carbonate</z:chebi> media, <z:mpath ids='MPATH_458'>normal</z:mpath> Jurkat cells strongly bind/take up Pt at a rate of 14.5 +/- 4.1 amol of Pt h-1 cell-1, while resistant cells strongly bind/take up 5.1 +/- 3.3 amol of Pt h-1 cell-1 </plain></SENT>
<SENT sid="13" pm="."><plain>Collectively, these studies show that <z:chebi fb="2" ids="31355">carboplatin</z:chebi> carbonato species may play a major role in the cytotoxicity and uptake of <z:chebi fb="2" ids="31355">carboplatin</z:chebi> by cells </plain></SENT>
</text></document>